Skip to content

Clinical trials

Choroidal Neovascularization trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20072
20102
20133
20141
20152
20181
20191
20203
20211
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Active, not recruiting2
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Ophthotech Corporation2
AbbVie1
Adverum Biotechnologies, Inc.1
Allergan1
European Georges Pompidou Hospital1
EyeBiotech Ltd.1
Fondation Ophtalmologique Adolphe de Rothschild1
Institut National de la Santé Et de la Recherche Médicale, France1
Notal Vision Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization22
Macular Degeneration16
Wet Macular Degeneration6
Vision Disorders4
Eye Diseases3
Geographic Atrophy3
Retinal Degeneration2
Retinal Diseases2
Angioid Streaks1
Blindness1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.